A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6
Authors
Keywords
Flow cytometry, Cell staining, Lymphocytes, Chemokines, Cloning, Antibodies, Immune cells, Inflammatory diseases
Journal
PLoS One
Volume 12, Issue 9, Pages e0184278
Publisher
Public Library of Science (PLoS)
Online
2017-09-06
DOI
10.1371/journal.pone.0184278
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway
- (2016) Qiang Wu et al. IMMUNOLOGY LETTERS
- Bispecific antibodies
- (2015) Roland E. Kontermann et al. DRUG DISCOVERY TODAY
- Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases
- (2015) Michela Silacci et al. mAbs
- CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis
- (2014) Adrian YS Lee et al. IMMUNOLOGY AND CELL BIOLOGY
- Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids
- (2014) Radha Ramesh et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
- (2014) Y. J. Yu et al. Science Translational Medicine
- Development of a Human IgG4 Bispecific Antibody for Dual Targeting of Interleukin-4 (IL-4) and Interleukin-13 (IL-13) Cytokines
- (2013) Christoph Spiess et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection
- (2012) Chung-Her Jenh et al. BMC IMMUNOLOGY
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains
- (2011) Jürgen Schanzer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stability engineering of scFvs for the development of bispecific and multivalent antibodies
- (2010) Brian R. Miller et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response
- (2009) A. Liston et al. JOURNAL OF IMMUNOLOGY
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
- (2009) Andrea Reboldi et al. NATURE IMMUNOLOGY
- Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease
- (2009) Eugene Y Chiang et al. NATURE MEDICINE
- Germline humanization of a murine Aβ antibody and crystal structure of the humanized recombinant Fab fragment
- (2009) Remy Robert et al. PROTEIN SCIENCE
- Moving targets: cell migration inhibitors as new anti-inflammatory therapies
- (2008) Charles R Mackay NATURE IMMUNOLOGY
- Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers
- (2008) R. Robert et al. PROTEIN ENGINEERING DESIGN & SELECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now